Sumitomo Chemical has announced to divest all of its shares in two of its flat panel display (FPD) process chemical subsidiaries in China to Zhenjiang Runjing High Purity Chemical Technology (Runjing Tech). The transaction is expected to be completed by the end of May this year. Financial details of the transaction were not disclosed.
Japan’s Sumitomo Chemical has completed the construction of a pilot facility using a highly efficient process for producing methanol from CO2 at its Ehime Works facility, located in Niihama City, Ehime Prefecture, Japan, and has started operations at the facility.
US biopharma Sumitovant – a wholly owned subsidiary of Japan’s Sumitomo Pharma – has closed its purchase of the remaining equity in Myovant Sciences, taking full control of the Swiss clinical-stage biopharma for about $1.7 billion. Myovant will now be delisted from the New York Stock Exchange.
Valent BioSciences, a US-based subsidiary of Japan’s Sumitomo Chemical, has acquired FBSciences, a Tennessee-based company specializing in biostimulants. Financial terms were not disclosed.
Japan’s Sumitomo Chemical has decided to sell its stake in Australian agrochemicals company Nufarm. Sumitomo’s holding represents 15.9% of Nufarm’s outstanding shares.
Fertilizer giant Yara has entered into a Memorandum of Understanding (MoU) with Sumitomo Chemical under which the Norwegian group will examine the supply of clean ammonia to the Japanese firm’s production plants. Sumitomo would use the clean ammonia for producing petrochemicals and plastics and/or distributing energy out of its plants in Japan.
German biopharmaceuticals contract development and manufacturing organization Rentschler Biopharma is extending and deepening its existing collaboration in Japan with Summit Pharmaceuticals International (SPI), a wholly owned subsidiary of Sumitomo.
